Introducing CEVHAP

A comprehensive approach to national

action plans is extremely important, but
successful implementation will hinge
upon having strong linkage between
effective hepatitis screening and
accessible treatment.

An effective policy framework can

prevent new infections, ensure people
can access clinical care, and reduce the
burden of infection at an individual,
country and regional level.
Professor Ding-Shinn Chen, Co-Chair of CEVHAP

Professor Stephen Locarnini, Co-Chair of CEVHAP

OUR MISSION
Visit us at www.cevhap.org or contact
us at info@cevhap.org
Alternatively, connect with us on:

To reduce the significant health, social and

economic burden of viral hepatitis in the Asia
Pacific region.

ACCESS INITIATE EDUCATE CHANGE

About CEVHAP

Leading Policy Reform in Asia

The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) was established in October
2010 as an independent, multidisciplinary body to advocate for public policy reform to
reduce the impact of viral hepatitis in Asia Pacific. The ultimate goal of the Coalition is to
eradicate viral hepatitis altogether.

In 2010 the 63rdWorld Health Assembly passed a resolution (WHA63.18), which for the first
time recognized the scale of the viral hepatitis epidemic and the international resolve needed
to tackle it. In response to this resolution, the World Health Organization (WHO) announced
that a global strategy would be developed to provide governments with a framework to deliver
real improvements in public health policies and established the Global Hepatitis Programme.
The goals of this programme are to reduce the:

The CEVHAP membership is comprised of many world-renowned hepatitis experts, including

people living with the infections. Utilizing the collective expertise of its members, CEVHAP works in
partnership with a broad range of stakeholders such as scientific and clinical experts, government
bodies, patient groups and other policy advocates to conduct public policy research and raise
awareness amongst policy makers about the social and economic impacts of viral hepatitis.
CEVHAP has members from across the region, including in Afghanistan, Australia, Bangladesh,
China, Hong Kong, India, Indonesia, Japan, Republic of Korea, Malaysia, Mongolia, Myanmar,
Nepal, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand and Vietnam. We also
have members and stakeholders from around the globe with whom we engage and exchange
including from Armenia, Germany, Ghana, Morocco, Turkey, Uganda, UK and USA.

Our Goals
1 Advocate and support initiatives that prevent transmission and increase
access to healthcare and support for all people living with viral hepatitis
2 Promote greater public awareness about viral hepatitis amongst policy influencers
3 Contribute to the development of strong viral hepatitis policies and national
strategies across Asia Pacific

What We Do
CEVHAP supports initiatives that aim to reduce the significant health, social and economic
burden of viral hepatitis in Asia Pacific. We work in collaboration with governments, clinicians,
people affected by the diseases, and other stakeholders to achieve greater public awareness,
prevention, management and access to treatment for all people living with the diseases.
Driven by their deep concern that the Asia Pacific region carries the largest portion (74%) of
the global disease burden of chronic viral hepatitis, CEVHAP membersencourage and assist
in national responses to viral hepatitis, and ensuring that clinical practice in the region is
consistent, up-to-date and well-informed.
CEVHAP is well placed to support national governments to review, refine and implement
national strategies and is undertaking various research projects to support governments
in their efforts to identify areas of unmet need in policy development. In addition to
influencing public policy, CEVHAP is committed to the development of programs that reduce
the devastating impact of viral hepatitis.

Transmission of agents that cause viral hepatitis

Morbidity and mortality due to viral hepatitis through improving the care of patients with
viral hepatitis
Socio-economic impact of viral hepatitis at individual, community and population levels.
A further resolution on hepatitis was passed on 22 May 2014, (WHA 67.6) at the 67th World
Health Assembly which strongly called upon every country to implement a national plan on
viral hepatitis.
To support the new resolution and the World Health Organisations 2014 global strategy
CEVHAP, in collaboration with the Australian Research Centre in Sex, Health and Society at
LaTrobe University,Melbourne, developed a plan of social and public health research to assist
countries to identify the essential components needed for a coordinated strategic response to
chronic viral hepatitis from the perspective of people living with viral hepatitis. This important
work is underway, with research to date having assessed the policy landscape in Taiwan, and
publication of a report on the needs of people with chronic viral hepatitis in five locations
across China.

A Spotlight on Asia
Since its inception, CEVHAP has continually called for a renewed international commitment
to address the health needs of the 340 million people who are affected by viral hepatitis in
Asia Pacific recognizing that a coordinated response is essential to combat two diseases that
together affect eight times as many people as those living with HIV, TB and malaria in the region.
Each year, on World Hepatitis Day (28th July) across the region, CEVHAP coordinates a broad
range of activities aimed at increasing awareness and education, engaging governments
and mobilizing stakeholders across the region. Working closely with the World Hepatitis
Alliance and CEVHAP members, the Coalition has generated a significant amount of coverage,
with high-profile interviews resulting in articles in the Wall Street Journal, Channel News
Asia, Central News Agency, Xinhua news wire, the Guardian Poverty Matters blog, Reuters
AlertNetAsia Views blog and SciDev.net.

COLLABORATE REFORM CO-ORDINATE